In the news

BostonScientific MedSurg EVP Dave Pierce shares his excitement for the future of our Endoscopy and Urology/Pelvic Health businesses, and why he’s proud of how the company has navigated through the uncertainty of the past year.

Boston Scientific has won FDA 510(k) clearance for a single-use bronchoscope designed to eliminate the infection risk associated with reusable devices.

Opinion: Boston Scientific's president of endoscopy writes that government policies have enabled the medtech giant to reinvest profits in multiple areas of innovation. "Patients cannot benefit from bets we don’t make.

A new study using Boston Scientific's EkoSonic endovascular system (EKOS) aims to address current gaps in clinical guidelines for the treatment of pulmonary embolism.

The advent of cardiac resynchronization therapy (CRT) changed the landscape of heart failure management options, but perhaps a third of patients receiving biventricular pacemakers for CRT don't respond to it. The observational study, SMART MSP, demonstrated that CRT with multisite LV pacing (MSP) made responders out of half of patients in whom CRT had failed over the previous 6 months in a prospective trial.